comparemela.com

Latest Breaking News On - ஜியோஃப் பேழைற் - Page 1 : comparemela.com

Apple (AAPL), Mind Cure Health (MCURF) - The Digital Therapeutics Market Is Redefining Psychedelic Research And Patient Care

The following article is sponsored by Mind Cure. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for informational purposes only. Digital therapeutics (DTx) are a form of patient care that are gaining momentum in the medical industry and the effects of the pandemic have only accelerated this growth.  In 2019, Insider Intelligence projected that the digital therapeutics industry would reach a market value of $9 billion by 2025. Although last year, their projections increased dramatically with the market value of DTx expected to hit nearly $56 billion in the next five years.

Mind Cure Announces Build-Out of Digital Therapeutics, iSTRYM: A Technology Platform for Mental Wellness Optimization & Psychedelic Research

Mind Cure iSTRYM (CNW Group/Mind Cure Health Inc.) As a life sciences and digital therapeutics company, providing speed to market with novel psychedelic therapies through deeper data analytics is a strength we are developing with iSTRYM. Further, as we build out our database for mental wellness, both therapists and individuals will get mental wellness protocols for wellness optimization and support. iSTRYM exists to become the source that individuals turn to for science-backed, personalized mental health support at scale. - Kelsey Ramsden, President & CEO.  Gaps between clients, researchers, and therapists create disparities in the collection of critical insights that arise outside of psychedelic-assisted therapy sessions, and ultimately prevent new scientific breakthroughs. Mind Cure s

North America Psychedelic Drugs Market Could Exceed $6 8 Billion By 2027

North America Psychedelic Drugs Market Could Exceed $6.8 Billion By 2027 - Financialnewsmedia.com News Commentary PALM BEACH, Fla., Jan. 6, 2021 /PRNewswire/ In the few places where cannabis is legal, it can be incredibly lucrative. In 2019, the nascent worldwide cannabis sector pumped out approximately $15 billion in sales. By 2024, that number is expected to triple. Not bad for an industry that, less than a decade ago, was entirely illegal almost everywhere on Earth and is still outlawed in most countries. Now, startups and investors are positioning to profit from psilocybin, LSD and other psychedelics. Despite Covid-19, a crashing economy and formidable legal obstacles, a growing number of entrepreneurs and investors are betting that medicines derived from psychedelic drugs can become a real business and more importantly…heal millions of people. They are joining the researchers, activists, philanthropists and journalists the who until now have been driving what s been called

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.